Trabeculectomy with mitomycin C for treatment of neovascular glaucoma in diabetic patients

Ophthalmologica

Volumn 220, Issue 6, 2006, Pages 383-388

  Kiuchi, Yoshiaki ^a   Sugimoto, Reiko ^b   Nakae, Kazuto ^b   Saito, Yoshihiro ^b   Ito, Shigeo ^b  

^a OSAKA GENERAL MEDICAL CENTER   (Japan)

^b OSAKA NATIONAL HOSPITAL   (Japan)

Author keywords

Diabetes mellitus; Mitomycin C; Neovascular glaucoma; Trabeculectomy

Indexed keywords

MITOMYCIN C;

ADHESION; ADULT; AGED; ARTICLE; CATARACT EXTRACTION; CLINICAL ARTICLE; CONTROLLED STUDY; CRYOTHERAPY; DIABETES MELLITUS; DIABETIC PATIENT; DIABETIC RETINOPATHY; DRUG EFFICACY; GLAUCOMA SURGERY; HUMAN; INTRAOCULAR PRESSURE; KAPLAN MEIER METHOD; NEOVASCULAR GLAUCOMA; RISK FACTOR; SURVIVAL RATE; TRABECULECTOMY; TREATMENT OUTCOME; VITRECTOMY;

ADULT; AGED; AGED, 80 AND OVER; COMBINED MODALITY THERAPY; CRYOTHERAPY; DIABETIC RETINOPATHY; FEMALE; GLAUCOMA, NEOVASCULAR; HUMANS; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; MITOMYCIN; RISK FACTORS; TRABECULECTOMY; TREATMENT OUTCOME; VISUAL ACUITY; VITRECTOMY;

EID: 33750899487     PISSN: 00303755     EISSN: None     Source Type: Journal    
DOI: 10.1159/000095865     Document Type: Article

References (25)

1. Gartner S, Henkind P: Neovascularization of the iris (rubeosis iridis). Surv Ophthalmol 1978;22:291-312.
2. Brown GC, Magargal LE, Schachat A, Shah H: Neovascular glaucoma etiologic considerations. Ophthalmology 1984;91:315-320.
3. Sivak-Callcott JA, O'Day DM, Gass JD, Tsai JC: Evidence-based recommendations for the diagnosis and treatment of neovascular glaucoma. Ophthalmology 2001;108:1767-1776.
4. Rockwood EJ, Parrish RK 2nd, Heuer DK, Skuta GL, Hodapp E, Palmberg PF, Gressel MG, Feuer W: Glaucoma filtering surgery with 5-fluorouracil. Ophthalmology 1987;94:1071-1078.
5. Kitazawa Y, Kawase K, Matsushita H, Minobe M: Trabeculectomy with mitomycin. A comparative study with fluorouracil. Arch Ophthalmol 1991;109:1963-1998.
6. The Fluorouracil Filtering Surgery Study Group: Three-year follow-up of the fluorouracil filtering surgery study. Am J Ophthalmol 1993;115:82-92.
7. Tsai JC, Feuer WJ, Parrish RK 2nd, Grajewski AL: 5-Fluorouracil filtering surgery and neovascular glaucoma. Long-term follow-up of the original pilot study. Ophthalmology 1995;102:887-892.
8. Katz GH, Higginbotham EJ, Lichiter PR, Skuta GL, Musch DC, Bergstrom TJ, Johnson AT: Mitomycin C versus 5-fluorouracil in high-risk glaucoma filtering surgery. Ophthalmology 1995;102:1263-1269.
9. Hyung SM, Kim SK: Mid-term effects of trabeculectomy with mitomycin C in neovascular glaucoma patients. Korean J Ophthalmol 2001;15:98-106.
10. Mandal AK, Majji AB, Mandal SP, Das T, Jalali S, Gothwal VK, Jain SS, Nutheti R: Mitomycin-C-augmented trabeculectomy for neovascular glaucoma. A preliminary report. Indian J Ophthalmol 2002 50:287-293.
11. May DR, Bergstrom TJ, Parmet AJ, Schwartz JG: Treatment of neovascular glaucoma with transscleral panretinal cryotherapy. Ophthalmology 1980;87:1106-1111.
12. Shihota R, Sanframouli S, Sood N: A prospective evaluation of anterior retinal cryoablation in neovascular glaucoma. Ophthalmic Surg 1991;22:256-259.
13. Ohnishi Y, Ishibashi T, Sagawa T: Fluorescein gonioangiography in diabetic neovascularization. Graefes Arch Clin Exp Ophthalmol 1994;232:199-204.
14. Blankenship GW: The lens influence on diabetic vitrectomy results. Report of a prospective randomized study. Arch Ophthalmol 1980;98:2196-2198.
15. Rice TA, Michels RG, Maguire MG, Rice EF: The effect of lensectomy on the incidence of iris neovascularization and neovascular glaucoma after vitrectomy for diabetic retinopathy. Am J Ophthalmol 1983;95:1-11.
16. Aiello LM, Wand M, Liang G: Neovascular glaucoma and vitreous hemorrhage following cataract surgery in patients with diabetis mellitus. Ophthalmology 1983;90:814-820.
17. Honjo M, Tanihara H, Inatani M, Honda Y: Mitomycin C trabeculectomy in eyes with cicatricial conjunctiva. Am J Ophthalmol 1998;126:823-824.
18. Sivalingam A, Kenney J, Brown GC, Benson WE, Donoso L: Basic fibroblast growth factor levels in the vitreous of patients with proliferative diabetic retinopathy. Arch Ophthalmol 1990;108:869-872.
19. Adamis AP: Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am J Ophthalmol 1994;118:445-450.
20. Sone H, Okuda Y, Kawakami Y, Hanatani M, Suzuki H, Kozawa T, Honmura S, Yamashita K: Vascular endothelial growth factor level in aqueous humor of diabetic patients with rubeotic glaucoma is markedly elevated [letter]. Diabetic Care 1996;19:1306-1307.
21. Tripathi RC, Li J, Tripathi BJ, Chalam KV, Adamis AP: Increased level of vascular endothelial growth factor in aqueous humor of patients with neovascular glaucoma. Ophthalmology 1998;105:232-237.
22. Chen KH, Wu CC, Roy S, Lee SM, Liu JH: Increased interleukin-6 in aqueous humor of neovascular glaucoma. Invest Ophthalmol Vis Sci 1999;40:2627-2632.
23. Sturmer J, Broadway DC, Hitchings RA: Young patient trabeculectomy. Assessment of risk factors for failure. Ophthalmology 1993;100:928-939.
24. Mermoud A, Salmon JF: Molteno tube implantation for neovascular glaucoma. Long-term results and factors influencing the outcome. Ophthalmology 1993;100:897-902.
25. Sidoti PA, Dunphy TR, Baerveldt G, LaBree L, Minckler DS, Lee PP, Heuer DK: Experience with the Baerveldt glaucoma implant in treating neovascular glaucoma. Ophthalmology 1995 ;102:1107-1118.